These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity. Nielsen UB, Adams GP, Weiner LM, Marks JD. Cancer Res; 2000 Nov 15; 60(22):6434-40. PubMed ID: 11103810 [Abstract] [Full Text] [Related]
3. A diabody that dissociates to monomer forms at low concentration: effects on binding activity and tumor targeting. Huang BC, Foote LJ, Lankford TK, Davern SM, McKeown CK, Kennel SJ. Biochem Biophys Res Commun; 2005 Feb 25; 327(4):999-1005. PubMed ID: 15652494 [Abstract] [Full Text] [Related]
5. Thermodynamics and kinetics of the reaction of a single-chain antibody fragment (scFv) with the leucine zipper domain of transcription factor GCN4. Weber-Bornhauser S, Eggenberger J, Jelesarov I, Bernard A, Berger C, Bosshard HR. Biochemistry; 1998 Sep 15; 37(37):13011-20. PubMed ID: 9737882 [Abstract] [Full Text] [Related]
6. Production of functionalized single-chain Fv antibody fragments binding to the ED-B domain of the B-isoform of fibronectin in Pichia pastoris. Marty C, Scheidegger P, Ballmer-Hofer K, Klemenz R, Schwendener RA. Protein Expr Purif; 2001 Feb 15; 21(1):156-64. PubMed ID: 11162401 [Abstract] [Full Text] [Related]
12. Cloning antifungal single chain fragment variable antibodies by phage display and competitive panning elution. Krishnaswamy S, Kabir ME, Miyamoto M, Furuichi Y, Komiyama T. Anal Biochem; 2009 Dec 01; 395(1):16-24. PubMed ID: 19665444 [Abstract] [Full Text] [Related]
13. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting. Villani ME, Morea V, Consalvi V, Chiaraluce R, Desiderio A, Benvenuto E, Donini M. Mol Immunol; 2008 May 01; 45(9):2474-85. PubMed ID: 18313757 [Abstract] [Full Text] [Related]
14. 125I-labeled anti-epidermal growth factor receptor-vIII single-chain Fv exhibits specific and high-level targeting of glioma xenografts. Kuan CT, Reist CJ, Foulon CF, Lorimer IA, Archer G, Pegram CN, Pastan I, Zalutsky MR, Bigner DD. Clin Cancer Res; 1999 Jun 01; 5(6):1539-49. PubMed ID: 10389943 [Abstract] [Full Text] [Related]
15. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer]. Wang Y, Li X, Chen W. Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan 01; 26(1):16-21. PubMed ID: 16495168 [Abstract] [Full Text] [Related]